SOPHiA GENETICS SA
SOPH- Exchange
- Nasdaq
- Industry
- Services-Computer Processing & Data Preparation
- SEC CIK
- 0001840706
In the last 90 days, SOPHiA GENETICS SA insiders filed 0 open-market purchases and 35 sales; 71 institutions reported holding it in 13F filings for Q2 2026, worth $212.5M in total; Akre Capital Management is the only superinvestor holding it.
Q2 2023 vs. Q1 2023
How the institutions holding SOPHiA GENETICS SA changed between Q1 2023 and Q2 2023.
All holders in Q2 2023All holders in Q1 2023
| Measure | Q1 2023 | Q2 2023 | Change |
|---|---|---|---|
| Holders | 34 | 35 | +1 |
| Shares | 18.3M | 17.9M | −371.9K (−2.0%) |
| Value | $90.9M | $80.2M | −$10.8M (−11.8%) |
New holders (4)
Institutions that held SOPHiA GENETICS SA at the end of Q2 2023 but not at the end of Q1 2023.
| Institution | Shares | Value | % of portfolio |
|---|---|---|---|
| Balyasny Asset Management LLC | 103,007 | $461.5K | 0.00% |
| Russell Investments Group, Ltd. | 52 | $233 | 0.00% |
| Simplex Trading, LLC | 190 | $0 | 0.00% |
| Meitav Dash Investments Ltd | 27,805 | – | – |
Sold out (3)
Institutions that held SOPHiA GENETICS SA at the end of Q1 2023 and filed for Q2 2023 without it.
| Institution | Shares, Q1 2023 | Value, Q1 2023 |
|---|---|---|
| Boothbay Fund Management, LLC | 57,843 | $287.5K |
| Two Sigma Securities, LLC | 18,129 | $90.1K |
| Jane Street Group, LLC | 16,091 | $80.0K |